Previous studies suggested that PDE2A and PDE4 expression was increased in brains of patients with AD and mouse models of AD, indicating that their involvement in AD pathology (Nabavi et al., 2019; Tibbo et al., 2019). Here, PDE2A is linked to Alzheimer disease.